Dachaigh › Aillse a' Bhroinn › Wisconsin › Madison
Sgrùdaidhean clionaigeach Aillse a' Bhroinn ann an Madison, WI
Tha aon sgrùdadh airson Aillse a' Bhroinn a’ lorg phàirtichean aig làrach ann no faisg air Madison. Fosglaidh e gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.
Teacsa sgrùdaidh oifigeil (Beurla)
A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
A’ fastadhÌre 2
- UW Health Carbone Cancer Center, Madison
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
- William S Middleton VA Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A’ fastadhÌre 2/3
- University of Wisconsin Carbone Cancer Center - University Hospital, Madison
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
A’ fastadhÌre 3
- University of Wisconsin Carbone Cancer Center, Madison
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
A’ fastadhÌre 2
- Research Site, Madison
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
A’ fastadhÌre 1
- University of Wisconsin - Carbone Cancer Center, Madison
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
A’ fastadhÌre 1/2
- The Board of Regents of the University of Wisconsin, Madison
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
A’ fastadhÌre 1/2
- University of Wisconsin- Madison, Madison
Lead-212 PSV359 Therapy for Patients With Solid Tumors
A’ fastadhÌre 1/2
- University of Wisconsin, Madison
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
A’ fastadhÌre 1
- UW Carbone Cancer Center, Madison
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
A’ fastadhÌre 2
- University of Wisconsin, Madison
Sgrùdaidhean Aillse a' Bhroinn ann am bailtean eile
- Houston, TX42 sgrùdaidhean
- Boston, MA32 sgrùdaidhean
- New York City, NY31 sgrùdaidhean
- Nashville, TN28 sgrùdaidhean
- Baldwin Park, CA22 sgrùdaidhean
- Los Angeles, CA22 sgrùdaidhean
- Arlington, VA20 sgrùdaidhean
- Dallas, TX19 sgrùdaidhean
- San Antonio, TX19 sgrùdaidhean
- St. Louis, MO18 sgrùdaidhean
- Grand Rapids, MI18 sgrùdaidhean
- Washington, DC16 sgrùdaidhean
Sgrùdaidhean eile ann an Madison
- Aillse Prostata29 sgrùdaidhean
- Aillse colorectal23 sgrùdaidhean
- Aillse a' bhroilleach22 sgrùdaidhean
- Ailse metastatach21 sgrùdaidhean
- Leukemia myeloid geur16 sgrùdaidhean
- Aillse Sgamhain Neo-chealla-beag16 sgrùdaidhean
- Melanoma15 sgrùdaidhean
- Aillse (gach seòrsa)14 sgrùdaidhean
- Cancer Ovarian13 sgrùdaidhean
- Cancer Pancreatic10 sgrùdaidhean
- Ailseachadh nan Sgamhan10 sgrùdaidhean
- Myeloma iomaill9 sgrùdaidhean
Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.